Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,569 | -13,765 | -63,386 | -50,284 | -34,717 |
| Depreciation Amortization | 1,131 | 565 | 1,642 | 1,114 | 632 |
| Accounts receivable | -59 | 56 | 24 | -28 | 39 |
| Accounts payable and accrued liabilities | -1,539 | -662 | 932 | 163 | 2,922 |
| Other Working Capital | -2,114 | -1,202 | 3,550 | 3,567 | 4,708 |
| Other Operating Activity | 5,444 | 2,535 | 6,765 | 5,378 | 708 |
| Operating Cash Flow | $-24,706 | $-12,473 | $-50,473 | $-40,090 | $-25,708 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -937 | -381 | -8,247 | -7,683 | -5,652 |
| Purchase Of Investment | N/A | N/A | -3,000 | -3,000 | -3,000 |
| Sale Of Investment | N/A | N/A | 38,200 | 38,200 | 35,200 |
| Investing Cash Flow | $-937 | $-381 | $26,953 | $27,517 | $26,548 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 3,700 | 3,700 | 3,700 |
| Debt Repayment | -2,571 | -1,029 | -1,300 | -1,300 | -1,300 |
| Common Stock Issued | 43,510 | 35,256 | 30,199 | 28,993 | 27,267 |
| Other Financing Activity | 0 | 0 | -591 | -591 | -394 |
| Financing Cash Flow | $40,939 | $34,227 | $32,008 | $30,802 | $29,273 |
| Beginning Cash Position | 43,152 | 43,152 | 34,664 | 34,664 | 34,664 |
| End Cash Position | 58,448 | 64,525 | 43,152 | 52,893 | 64,777 |
| Net Cash Flow | $15,296 | $21,373 | $8,488 | $18,229 | $30,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,706 | -12,473 | -50,473 | -40,090 | -25,708 |
| Capital Expenditure | -937 | -381 | -8,252 | -7,688 | -5,652 |
| Free Cash Flow | -25,643 | -12,854 | -58,725 | -47,778 | -31,360 |